" /> Autologous Anti-CD5 CAR T-lymphocytes MB-105 - CISMeF





Preferred Label : Autologous Anti-CD5 CAR T-lymphocytes MB-105;

NCIt synonyms : Autologous CD5-specific CAR T-cells MB-105; Autologous CD5-targeted CAR-T cells MB-105; Autologous Anti-CD5 CAR-T Cells MB-105; Autologous Anti-CD5 CAR T-cells MB-105; Autologous CD5CAR-expressing T-lymphocytes MB-105;

NCIt definition : A preparation of genetically modified autologous T-cells expressing a chimeric antigen receptor (CAR) directed against cluster of differentiation 5 (CD5), with potential immunomodulating and antineoplastic activities. Upon administration, the autologous anti-CD5 CAR T-lymphocytes MB-105 target and bind to CD5-expressing tumor cells, thereby inducing selective cytotoxicity in CD5-expressing tumor cells. CD5 is a T-cell surface glycoprotein expressed on the surface of normal T-cells and overexpressed on various B- and T-cell malignancies.;

Molecule name : MB 105; MB-105;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.